Results 231 to 240 of about 18,617 (285)

Infant Diet Is Associated With BMI Later in Childhood: A Nation‐Wide Mother‐Child Cohort Study in Iceland (ICE‐MCH)

open access: yesMaternal &Child Nutrition, Volume 22, Issue 1, March 2026.
ABSTRACT Few studies have explored associations between indexes incorporating both breastfeeding and complementary feeding and future risk of overweight/obesity. The aim of this study was to explore associations between a previously developed Infant Diet Score (IDS; higher score reflecting better alignment with breastfeeding and complementary feeding ...
Jenny Jonsdottir   +3 more
wiley   +1 more source

Tau Phosphorylation as an Adaptive Physiological Response: Implications for the Therapy of Tauopathies

open access: yesThe FASEB Journal, Volume 40, Issue 4, 28 February 2026.
Drawing on recent studies suggesting that tau phosphorylation is reversible, therapies for tauopathies could enhance reversibility, for example, by dismantling aggregated tau species. ABSTRACT Recent evidence demonstrates that tau phosphorylation, traditionally viewed as a hallmark of neurodegeneration, also occurs in completely reversible ...
Timothy Daly, Bruno P. Imbimbo
wiley   +1 more source

Growth Hormone‐Loaded 3D Printed Silk Fibroin‐Cellulose Dressings for Ischemic Wounds

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 5, 2 February 2026.
3D‐printed wound dressings combining carboxymethyl cellulose, silk fibroin, and growth hormone accelerate healing in diabetic ulcers. These bioactive, customizable dressings enhance angiogenesis, cellular proliferation, and immune modulation. Proteomic analysis reveals activation of regenerative pathways and reduced fibrosis, highlighting their ...
Maria Pita‐Vilar   +7 more
wiley   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo   +22 more
wiley   +1 more source

Improvement of EPO Transgene Detection From Polymeric Dried Blood Spots for Antidoping Application

open access: yesDrug Testing and Analysis, Volume 18, Issue 2, Page 230-238, February 2026.
This article presents an optimized protocol for gene doping detection. Starting from one spot DBS (20 μL), concentrated DNA was obtained and real‐time PCR parameters were adjusted for increased detection. Robust detection of 5000 copies/mL of transgene was validated for polymeric device TASSO M‐20.
Alexandre Marchand   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy